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Pre-hospital ECG's were obtained in 2,011 (6.3%) of 31,939 NRMI-2 pa- 
tients who presented to the hospital within 12 hours of an AMI from 6/94 to 
7/95. Transfer or self-transport patients were excluded from this study. Me- 
dian t~me from AMI symptoms onset until hospital ardval was longer among 
those Vested with PH-ECG (2.8 hm vs 1.7 hrs, p < 0.001). However, once 
in the hospital, the PH-ECG treated group conferred a shorter median time 
to the initiation of reperfosion therapy with either thrombelysis (31 min vs 40 
rain, p < 0.001) or pdmory angioptasty (87 rain vs 117 rain, p < 0.001). 
The PH-ECG group was more I~ely to receive thrombelytic therapy (45% 
vs 38%, p < 0.001) and undergo pdmary angioplasty (18% vs 10%, p < 
0.001). Also, the PH-ECG group was more likely to obtain In-hospitat cardiac 
catheterization (54% vs 39%, p < 0.001), angioplasty (21% vs 15°/o, p < 
0,001) or bypass surgery (10% vs 6%, p < 0.001). Hospital mortality was 
7.9% in the PH-ECG group and 12.2% in those without PH-ECG (Io < 0.001 ). 
Alter adjusting for baseline differences utilizing multivariate analysis, this 
mortality difference remained statistically significant (p = 0.02). 
In NRMI-2, the pre-hespital ECG in diagnosing AMI leads to the wider, 
faster in-hospitat utilization of repertusion strategies, as well as the greater 
use of invesive procedures. These factom may help explain the mortality 
advantage seen in the PH-ECG treated group. 
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~ ABC-Leslon Risk Factor for the Type as 
Occurrence of Early and Late Clinical Events in 
Unstable Patients Following Trenslumlnal 
Coronary Angioplasty (PTCA) 
Jean-Paul R. Herrman, Rein Melkert, Rudiger Simon 1, Patrick W. Serruys, 
for the HELVETICA investigators. ~Medizinische UniversitatskUnik, Kiel, 
Germany and Thoraxcentre, Rotterdam, the Netherlands 
Introduction: This study was performed to investigate the relationship be- 
twesn ABC lesion type (AHA/ACC) and eady and tats adverse clinical events 
(4 and 210 days post-PTCA) such as death, myocardial infarction (MI), bail- 
outs, bypass surgery (CABG) and re-PTCA which hamper esults of PTCA. 
Methods: Study population compdsed 1140 patients, prospectively enmled 
in the HELVETICA study, in which hirudln (Hit) iv or iv + sc was compared to 
heparin (Hap) treatment in unstable patients undergoing PTCA for 163 type 
A, 447 type St, 416 type B2 and 114 type C lesions. In case of muitHesion 
dilatation, the most severe lesion type was considered. 
Results: The table presents eady and late ranked clinical ~vent rate in 
percent per lesion type. P-value is from chi-square test for categodcai ranked 
non-parametric variables. 
E~tdy events Late events 
Hir iv + sc Hir iv Hap Total Hit iv + sc Hit iv Hep Total 
N - 378 381 381 1140 378 381 381 1140 
A (N = 163) 1.8 3.6 4.0 3.1 24.6 32,1 16.0 24.5 
B1 (N- 447) 5.6 5.4 7.7 6.3 32.2 33.6 30.3 32.0 
B2 (N = 416) 6.6 12.0 15.3 11.3 36.5 43.0 38.7 39,4 
C (N - 114) 7.3 8.8 17.9 11.4 26.8 20.4 43,6 33.3 
~value NS NS 0.03 0.00 NS N$ 0.01 0,00 
Conclusion: The overall early and late clinical outcome is significantly 
impaired when lesion severity incmasas. This dstdmental trend in clinical 
outcome related to lesion sevedty is however prevented by the use of hirudin. 
~ Plssma Changes in Flbrinolytic end Coagulation 
Activity After PTCA 
Madhu K. Natarajan, Jerome Teitsl, Herbert I-au, Robert Chisholm, 
Bradley Strauss. St. Michasrs Hospital. Toronto, Canada 
Although ypoflbdnolysis and hypercoagulability may be contributing factors 
to restenosis no single study has comprehensively analysed these changes. 
In a pilot study, plasma fibdnolytio and coagulation activity were sedally 
followed for 3 months in 20 patients with stable angina treated with single 
vessel coronary angloplasty. As shown below, we found an eady transient 
fall in PA:-I, highly significant by one-way ANOVA. 
Notably, PAl-1 values pro-PTCA and at all times beyond 6 hr post-PTCA 
were above the normal limit of 30 IU/ml. Urokinase(uPA) levels showed a 
sustafned, significant increase beginning on day 3, An eady, non-significant 
increase in IPA and shortening of the euglobulifi lysls lime were also seen 
(not shown). Factor VII activity fell from 120 4- 10% pre PTCA to 91 4.11% 
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pest (p < 0,005) and returned to baseline levels by 24 hours. RYe of the 
20 patients required ropeat PTCA for restenosis. This subgroup had higher 
initial PAI-I levels and no dse in uPA activity on sedat measurement. 
Conclusions: Patients with stable angina have elevated PAl-1 levels which 
transiently decrease post PTCA. Elevated PAl-1 activity unopposed by an 
insmase in uPA activity may predispose to mstanosts. Based on these results 
we have initiated a larger study with mandatory repeat angtography at 6 
months. 
~ L a t e  Regression of the Dilated Lesion Alter 
Coronary Angloplasty: A 5 Year Quantitative 
Angiogrephlc Study 
John A. Ormiston, Fiona M. Stewart, Antony H.G. Roche, Bruce Webber, 
Mark W.I. Webster. Green Lane Hospital, Auckland, New Zealand 
Although clinical restenosis is uncommon beyond 6 months following coro- 
nary angioplasty (PTCA), them is little quantitative angiographio information 
on long-term changes at the PTCA site. 
Of 127 consecutive patients (pts) with successful PTCA, follow-up cinean- 
giography was obtained 'early' at 2-13 months (moan 7) in 125 pts and 
'late' at 1.5-7.8 years (mean 4.5) in 82 pts (113 lesions).-'Late' angiography 
was performed in 85%0 of those eligible; pta were excluded for repeat PTCA 
(22), mvasculadzation surgery (4) or death (3). Quantitative angiographic 
measurements (CMS-Medls) are mean 4- SD. 
PTCA Follow-Up 
Before Immediate 'Early' 'Law 
MLO (mm) 0.83 4- 0.42 1.90:1:0.48 1 .P,6 ± 0.54 2.12 :E 0.59 
Oiameler 70.3 <- 14.9 34.0 4-12.1 36.2 4-14.2 29.0 ± 11.7 
Stenosis (%) p < 0.001 p = ns p < 0.001 
Between 'eedy' and 'late' follow-up, the minimum lumen diameter (MLD) 
of 45 lesions improved by morn than 2 SD of repeat measuremanta, nd 9 
detsdorated. No patient with a lesion of < 60% diameter stennsis at 'early' 
anglography had a lesion of > 50% stenosis at 'late' aegiagraphy. 
Regression of lesion eavedty between 6 months and 5 years after PTCA is 
a frequent occurrence. This study sheds light on the matanotio process and 
may influence management of lesions of moderate severity 6 months after 
PTCA, 
~ Acute Gain and Late Loss Relationship After 
Coronary Angioplssty Correlates With Geometric 
Remodeling but Not With Changes In Plaque 
Volume 
Takeshi Kimure, Satushl Kaburegi, Himyoshl Yokoi, Yoshihlsa Nakagawa, 
Masaldyo Nobuyoshl, Gall S. Mintz, Jeifery J. Popmo, Martin B. Leon. 
KiPakyushu, Kokura Memorial Hospital, Japan, Washington Hospital Center, 
Washington DC 
Well-known relationship between acute gain lAG) and late loss (LL) after 
coronary angloplasty has been a priori explained by inflma] hyperplasla In 
mspense to injury. AG and LL relationship was analyzed in a cohort of patients 
enrolled in a prospective study by eadai intravascutsr ultrasound (IVUS) 
(motodznd pullback @ 0.5 turn/sac) and quantitative comnanj angiegraphy 
(QCA) (CAAS II) after balloon angioplasty (BA) and directional coronary 
atheroctomy (DCA). Serial studies (pre, past, and 6 months (mos)) with 
adequate IVUS images were completed in 65 lesions (DCA 28, BA 37) (93%) 
out of 70 eligible lesions. The anatomic slice selected for eadai analysis had 
an axlallocation within the target lesion atthe smallest pre-intervention lumen 
cross.sectional rea. 
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Regression Analysis 
&Lumen pre - post (Acute Gain) 
IVUS{4.78,~2.24mm 2) QCA{I.324.0.61mm) 
&Lumen post-6 mos R = 0.38 P - 0.002 R - 0.51 P = 0.0001 
AEEM (-0.79 4. 2.87 mm 2) R - 0.4 P = 0.0009 R = 0.28 P - 0.025 
&P+M(1.264.2.STmm 2, R=0.06 P-0.64 R=0.01 P=0.92 
• ',Lumen post - 6 mos {Late Loss) 
IVUS(-2.054.2.65mm 2) QCA(-0.56:E0.64mm) 
AEEM(-0.79:I:2.87mm 2) R-0.57 P-0.0001 R=0.38 P-0.0036 
AP+M(1.264.2.57mm 2) R=0.4 P-O.0011 R-0.32 P=0.009 
EEM = External Elastic Membrane, P + M = Plaque + Media 
Significant positive corretation between AG and LL was again deroon- 
sPated by beth IVU$ and QCA in this prospectiveN collected cohort of 
patients with high rate of follew-up study. Both &EEM and A P + M corre- 
lated well with LL However, AEEM but not A P + M correlated with AG. 
In conclusion, geometric remodeling but not changes in plaque volume was 
considered to be a generalized response to injury. 
~ D o e s  Coagulat ion Act ivat ion  Cause ReMenosis  in 
Pat ients Undergo ing  Direct ional  coronary  
Atherectomy?  
M. Lins, K. H, Zurbom, O. Dau, $. Muuding, G. Henmano, R. Simon. Dept. 
of Cardiology, University of Kiel, Germany 
Restenosis is a major problem of peroutaneous transluminal coronary an- 
gloplasty (PTCA) and related procedures. To better understand the under- 
lying pathophysio!ngic mechanisms, coagulation and fibrinolytic vodables 
were analysed prospectively in 36 pts after directional coronary atherectomy 
(OCA) and in 20 control pte undergoing diagnostic heart ,.:athetedzation and 
coronary angiography. Blood samples were taken before and 1 h, 24 h and 
48 h after the procedure. They revealed coagulation activation with a signifi- 
cant increase in proothrombin fragments (F1 + 2) from 0.75 to 0.97 nmoPl (P 
< 0.01) and throrobin-antithrombin III complexes {TAT) from 2.9 to 6 pg/l (P 
< 0,01) after 24 h. No significant changes were found in the control pts. No 
subecute thrombosis or unstable angina were documented in any pt. In 8 out 
of these 36 pte late restenosis (R+)was diagnosed dudng follow-up angiogra- 
phy 3-6 months after DCA. In these pts FI + 2 rose from 0.68 to 0,89 nmoPl 
(P < 0.01) and TAT from 3.2 to 4.7 pg/I (P < 0.01), but not significantly in 
pts without restenosis (R-). In pts with late restenosls plasminogen activator 
inhibitor (PAl-l) also increased from 2.4 to 4.9 U/ml (P < 0.05) 24 h after 
DCA white there were no significant changes in pta without restenosis and in 
control pts, O-Dlmer/rAT ratio indicating balance between dotting activation 
and tibdnotysis was significantly lower in restenosls pta after 24 h. 
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The findings suggest that coagulation activation and hypofibdnolysis during 
48 h after DCA could be risk factors for the development of late restenoals. 
• Relation Between Minimal Luminal Dimensions 
and Myocard ia l  Perfuaion Reserve Immediate ly  
After  Stent ing and  st  6 Months  Fo l low-up 
Michael Haude, Dietrich Baumgart, Guido Caspari, G0nter G6rge, 
Junbo Ge, Raimund Erbel. Cardiology Department, University Essen, 
Essen, Germany 
it has been shown that coronary flow velocity reserve as measured by 
intranoronary Doppler ultrasound and myocardial perfusion reserve (MPR) 
meesuled by X-ray densltometry can generally not be restored to normal 
values after coronary balloon angioptasty (PTCA). In order to evaluate the 
addifional impact of luminal widening (residual minimal luminal diameter 
(MLO) and cress-sectional area (MCA)) after coronary stenting on rnyocardia~ 
pedusion reserve we measured post-stanotio and reference MPR in 25 
patients with a proximal stenosis of the left anterior de~cen¢ling artery before 
PTCA, after PTCA (twice 10 atm for 30 s, I~llcon/artery ratio 1:1), after 
adjunct stenting (15 mm PS-Stent, 10 utm for 30 s, balloon/artery ratio 
1:1) and at 6 months follow up. Atl patients had no myocardial infarction, 
LV hypertrophy or diabetes. MPR was calculated as the ratio of baseline 
mean dee time (RT) and hyperemic (12 rag papaverine ic) RT, derived from 
densilometric evaluation of digital subtraction coronary angiegrama. 
Results 
Betore PTCA After PTCA After sterR At follow.up 
MLD[mm] 0.99:t:0.49 2.044.0.33# 3.15~:0.36 $ 2.18±0.57 +
MCAlmm 2] 0.97±0.74 3.35:E1.12# 7.87:t:1.72 $ 3.97:J:1.88 + 
Post-stanotic MPR 1.6 :J: 0.2 2.5:1: 0.8# 3.1 ± 0.5§ 2.8 ± 0.6 
Reference MPR 3.0 ± 0.3 3.0 ~ 0.3# 3.2 ± 0.3 3.0 ± 0.4 
ANOVA: #p < 0,01 remus before PTCA. §p < 0,05 versus after PTCA, Sip <: 0.01 versus 
after PTCA. +p < 0.01 versus after stenL 
There is a linear relation between MLD and post-stenotic MPR (MPR = 
0.52.MLD + 1.45; r = 0.87, SEE = 0.25) and a non-linear relation between 
MCA and post-stenotic MPR (MPR = -0.01-MCA 2 + 0.29-MCA + 1.72, r 
= 0.87, SEE = 0.25) during the intetventional procedure with restoration of 
post-stenotic MPR after stenting to normal reference levels. At 6 months both 
relations showed a steeper slope (MPR = 0.91.MLD + 0.67, r = 0.89, SEE 
= 0.23 and MPR = -0.04.MCA 2 + 0.57.MCA + 1.11, r = 0.87, SEE = 0.25) 
suggesting a long-term recovery of myocardial vascular capacity despite 
progressive luminal rananowing at the stanted vessel site. 
~ Ef fect iveness o f  Probucol  In Prevent ing  
Reetenosis  Af ter  Percutaneous "rransluminal  
Coronary  A( ,g icplacty:  Probucol  Ang iop lasW 
Rectanosis  Trial (PART) 
Hisashi Yokoi, Hireshi Yamaguchi, Yolchi Kuwabara 1 , for the PART Group. 
Juntendo Univora#y, Tokyo, Japan; 1 Chlba University, Chiba, Japan 
Oxidized low-density lipaprotein is an important activator that may play a 
role in etiological process for restenosis. Probucol has been known to have 
antioxidant properties as well as lipid lowering effect.. In animal models 
antioxidant therapy showed a beneficial effect on restenosis. Therefore, a 
prospective randomized control study was designed to clarify the prevP'~tive 
effect of Probucol on restenosis after PTCA. One hundred and one patients 
were randomly assigned for Probucol or control group by using minimization 
method. In Probucol group, 1000 mg of Probucol was administered daily 
4 weeks pdor to PTCA, and continued for observation period. In control 
group, no anti-hypedipidemic drug was administered. One PTCA region of 
interest per patient was specified at registration, and quantitative coronary 
ang/agraphy was performed before PTCA, soon and at least 16 weeks after 
PTCA. Restenosls was defined as a recurrent luminal stenosls of more than 
50% In the dilated segment at the time of restudy. Seventy eight patients 
(40 for Probucol and 38 for control) completed the study, and was used in 
the analysis. In Probucol group, mean total cholesterol level, low-density 
lipoproteln cholesterol level and high-densify Ilpoproteln cholasterot level 
decreased from 201 to 160, from 145 to 116, from 37 to 25 mg/di,respectlvety 
(p < 0.05 vs control). The results of QCA were as follows: 
Probucol Control 
Acute gala (ram) 1.14 4. 0.42 1,08 =1:0,54 n.s. 
Late loss (ram) 0.374.0.69 0.004.0.62 n,s. 
Net gain (ram) 0.774.0.70 0.48±0.59 p < 0.05 
Restenosis rate in Probucol group was 23% which was significantly lower 
than that in control group, 57% (p < 0.01). Multivariate analysis showed that 
this effect was independent of change in lipid level. 
In conclusion, Probucol administered 4 weeks prior to PTCA was effective 
in preventing restenosis after PTCA. 
